Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen L Cochi

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
The Journal of Infectious Diseases|April 24, 2004
Global measles elimination efforts: the significance of measles elimination in the United StatesPeter M Strebel, Ana-Maria Henao-Restrepo, Edward Hoekstra, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|July 8, 2020
Updated Characterization of Post-OPV Cessation Risks: Lessons from 2019 Serotype 2 Outbreaks and Implications for the Probability of OPV RestartDominika A Kalkowska, Mark A Pallansch, Stephen L Cochi, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|March 7, 2013
Preeradication vaccine policy options for poliovirus infection and disease controlKimberly M Thompson, Mark A Pallansch, Radboud J Duintjer Tebbens, et al.
The Journal of Infectious Diseases|June 14, 2011
A world without measlesPeter M Strebel, Stephen L Cochi, Edward Hoekstra, et al.
The Journal of Infectious Diseases|August 26, 2017
Transition Planning For After Polio EradicationPaul D Rutter, Alan R Hinman, Lea Hegg, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|March 26, 2013
Characterizing poliovirus transmission and evolution: insights from modeling experiences with wild and vaccine-related poliovirusesRadboud J Duintjer Tebbens, Mark A Pallansch, Dominika A Kalkowska, et al.
BMC Infectious Diseases|January 30, 2014
The potential impact of expanding target age groups for polio immunization campaignsRadboud J Duintjer Tebbens, Dominika A Kalkowska, Steven G F Wassilak, et al.
Vaccine|May 8, 2021
The impact of disruptions caused by the COVID-19 pandemic on global polio eradicationDominika A Kalkowska, Arend Voorman, Mark A Pallansch, et al.
BMC Infectious Diseases|April 19, 2015
Modeling undetected live poliovirus circulation after apparent interruption of transmission: implications for surveillance and vaccinationDominika A Kalkowska, Radboud J Duintjer Tebbens, Mark A Pallansch, et al.
The Journal of Infectious Diseases|August 26, 2017
Contribution of Global Polio Eradication Initiative-Funded Personnel to the Strengthening of Routine Immunization Programs in the 10 Focus Countries of the Polio Eradication and Endgame Strategic PlanMaya M V X van den Ent, Rachel D Swift, Sameer Anaokar, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
The Journal of Infectious Diseases|April 24, 2004
Global measles elimination efforts: the significance of measles elimination in the United StatesPeter M Strebel, Ana-Maria Henao-Restrepo, Edward Hoekstra, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|July 8, 2020
Updated Characterization of Post-OPV Cessation Risks: Lessons from 2019 Serotype 2 Outbreaks and Implications for the Probability of OPV RestartDominika A Kalkowska, Mark A Pallansch, Stephen L Cochi, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|March 7, 2013
Preeradication vaccine policy options for poliovirus infection and disease controlKimberly M Thompson, Mark A Pallansch, Radboud J Duintjer Tebbens, et al.
The Journal of Infectious Diseases|June 14, 2011
A world without measlesPeter M Strebel, Stephen L Cochi, Edward Hoekstra, et al.
The Journal of Infectious Diseases|August 26, 2017
Transition Planning For After Polio EradicationPaul D Rutter, Alan R Hinman, Lea Hegg, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|March 26, 2013
Characterizing poliovirus transmission and evolution: insights from modeling experiences with wild and vaccine-related poliovirusesRadboud J Duintjer Tebbens, Mark A Pallansch, Dominika A Kalkowska, et al.
BMC Infectious Diseases|January 30, 2014
The potential impact of expanding target age groups for polio immunization campaignsRadboud J Duintjer Tebbens, Dominika A Kalkowska, Steven G F Wassilak, et al.
Vaccine|May 8, 2021
The impact of disruptions caused by the COVID-19 pandemic on global polio eradicationDominika A Kalkowska, Arend Voorman, Mark A Pallansch, et al.
BMC Infectious Diseases|April 19, 2015
Modeling undetected live poliovirus circulation after apparent interruption of transmission: implications for surveillance and vaccinationDominika A Kalkowska, Radboud J Duintjer Tebbens, Mark A Pallansch, et al.
The Journal of Infectious Diseases|August 26, 2017
Contribution of Global Polio Eradication Initiative-Funded Personnel to the Strengthening of Routine Immunization Programs in the 10 Focus Countries of the Polio Eradication and Endgame Strategic PlanMaya M V X van den Ent, Rachel D Swift, Sameer Anaokar, et al.
Pageof 6